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1ABSTRACT
The role of Chitotriosidase in Regulation of Allergen-induced Airway 
Inflammation 
Jung Yeon Hong
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Myung Hyun Sohn)
The mammalian true chitinase, Acidic mammalian chitinase (AMCase) and 
chitotriosidase (Chitnase 1, Chit1), were known to be important regulators of 
inflammation and remodeling. Allergic asthma is the immunologic hypersensitive 
disease which is characterized by eosinophil recruitment, increase of mucus 
2secretion and airway hyperresponsiveness. During asthma development, Th2 cells 
modulate pathological symptoms of asthma by secretion of IL-4, IL-5 and IL-13. 
However, the specific role and mechanism by which Chit1 regulates Th2 responses 
has not been fully defined.
To explore the contribution of Chit1 during allergic inflammation, wild type (WT) 
and chitotriosidase deficiency (Chit1-/-) mice were subjected to ovalbumin (OVA) 
or house dust mite (HDM) sensitization and challenge. Bronchoalveolar lavage 
fluid (BALF) cell number and differential were assessed, cytokines and total and 
OVA-specific IgE were evaluated using enzyme-linked immunosorbent assay 
(ELISA) and airway hyperresponsiveness (AHR) to metacholine was measured by 
with a Flexivent apparatus. The proportion of CD4+Foxp3+ cells and CD4+GATA3+
cells were determined by flow cytometry.         
In OVA-challenged Chit1-/- mice, Th2 cytokine production, eosinophil infiltration, 
IgE production and AHR were increased compared to WT mice. The levels of TGF-
β1 and IL-10 expression were also significantly decreased in the lungs of Chit1-/-
3mice. The ratio of CD4+Foxp3+/CD4+GATA3+cells and their mRNA level were 
significantly diminished in Chit1-/- mice compared to WT mice. In naïve mice, the 
percentage and proliferation of Treg cells were comparable to WT cells. In vitro 
studies, Chit1-/- CD4+CD25-T cells upregulated Foxp3 and TGF-β receptors 
following TGF-β1 and rChit1 stimulation as much as WT CD4+CD25- T cells. In 
addition, Chit1-/- CD4+CD25+ Treg cell displayed similar suppression ability in 
APC–stimulated CD4+CD25- T cells, as compared with WT CD4+CD25+ Treg cells. 
Collectively, these results indicate that Chit1 play a protective effect against
allergen-induced allergic airway inflammation and airway responses potentially 
through the regulation of Foxp3+Treg cells.
___________________________________________________________________
Key words: chitotriosidase, asthma mouse model, Foxp3+ regulatory T cell, TGF-β
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The Graduate School, Yonsei University
(Directed by Professor Myung Hyun Sohn)
I. INTRODUCTION
Asthma is one of the most common chronic diseases in the world, affecting 
people of all ages and ethnic backgrounds.1 It is characterized by airway 
hyperresponsiveness, chronic pulmonary eosinophilia, elevated serum IgE, 
excessive mucus production, and airway remodeling.2 In asthmatics, CD4+ Tcells 
producing IL-4, IL-5 and IL-13 have been identified in BALF and airway biopsies. 
5After antigen challenge in allergic asthmatics, these cytokines and Th2 
lymphocytes are increase in the airway. Because Th2 cytokines are required for the 
development of airway eosinophilia and IgE, it has been proposed that Th2-cells 
stimulate an inflammatory response that results in asthma.3,4 However, mechanisms 
underlying the pathogenesis of asthma are not fully understood. 
Th2-cell driven inflammation is likely to represent an abnormal response to 
allergens. These reactions are normally suppressed by regulatory T cells (Treg), 
which are essential in the maintenance of immunological tolerance and represent a 
major pathway proposed to contribute to the maintenance of immune homeostasis 
in the airways. The forkhead box P3 (Foxp3), which is encodes a transcription 
factor, has been shown to be not only specifically expressed in professional Treg, 
but also required for their development.5 CD4+Foxp3+ Treg consist of two 
indistinguishable subsets induced in either the thymus (called natural Tregs or 
nTregs) or the periphery (called induced Tregs or iTregs).6 In mouse, 
CD4+CD25−Foxp3− cells can be induced to express Foxp3 when activated in vitro 
6by TCR stimulation in the presence of TGFβ appear to resemble nTregs in all their 
phenotypic and functional properties. They exert potent suppressor function in vitro 
and can prevent or control disease in vivo.7
Chitinases are a pivotal component of the host response to chitinous organism.8
Mammals encode two functional chitinases, chitotriosidase (Chit1, chitinase 1) and 
acidic mammalian chitinase (AMCase).9 In recent years, there are mounting 
evidences demonstrating that mammalian chitinases may play a key role in 
mediating the T-helper 2 cell-driven inflammatory response.10,11 Chit1 is the most 
readily appreciated true chitinase in mammals and man.1,12,13 Recently, Vicencio et 
al14 studied that severe asthma children with fungal sensitization were carried a 
mutation in CHIT1 and CHIT1 mutations may increase the risk of pulmonary 
fungal infection or colonization, thereby facilitating sensitization and complicating 
lung disease. Animal experimentation has also demonstrated significant changes in 
Chit1 expression at sites of inflammation, remodeling, and fibrosis.15,16 However, 
the roles of Chit1 in the pathogenesis of tissue inflammation in asthma are 
7unknown. Here, we showed that chit1 is up regulated in the lungs and GATA3+ T 
cells of allergen-induced mice compared to control animals. 
In this present study, Chit1-/- leads to increased Th2 polarization shown by 
elevated concentrations of IL-4, IL-5 and IL-13 and increased the ratio of 
GATA3+/Foxp3+ T cells in the lung in a murine model of allergic asthma. 
Furthermore, the addition of recombinant TGF-β1 and/or Chit1 induced the Foxp3+
T cells in vitro, providing insight into the function of Chit1 in allergic asthma. Our 
studies also demonstrate that Chit1 concentration is increased in the pediatric 
patients with asthma. 
8II. MATERIALS AND MEHTODS
1. Animals
All experiments used 7-13-wk-old, sex- and age-matched mice that were housed 
under specific pathogen-free conditions. Chitotriosidase null mutant (Chit1-/-) mice 
were a generous gift from Jack Elias (Brown University, RI, USA) and generated on 
C57BL/6 background as previously described.17 OT-II mice were purchased from 
Jackson Laboratories (Ba Harbor, ME, USA). All animal experiments were 
performed in compliance with Korea Research Institute of Bioscience and 
Biotechnology and approved by the institutional review boards of Yonsei 
University College of Medicine Council of Science and Technology.
2. Ovalbumin and house dust mite challenge 
Specific-pathogen-free female wild type (WT) and Chit1-/- mice were sensitized by 
intraperitoneal injection (i.p) of 20 μg OVA (Sigma-Aldrich, St. Louis, MO, USA), 
with 2 mg aluminum hydroxide (Pierce, Thermo scientific, Rockford, IL) in 200 μl, 
9on days 1 and 14. The mice underwent intranasal (i.n) challenges with 1% OVA in 
PBS or PBS alone (control mice) on days 28-30. They were sacrificed 1 day after 
the final challenge and their lungs were evaluated. 
Mice were immunized with two i.p of 10 μg house dust mite (HDM) (Greer 
Laboratories, Lenoir, NC) with 2 mg aluminum hydroxide in 200 μl, on days 1 and 
5. Starting on day 12, mice were challenged by i.n with 50 μg HDM in PBS or PBS 
alone (control mice) daily for 3 day.
3. Inflammatory cell counts in bronchoalveolar lavage (BAL) fluid
After last challenge, lung was lavaged with 2 X 0.9 mL PBS. The lavage fluids 
were centrifuged, bronchoalveolar lavage (BAL) fluid cells isolated, and the 
supernatant frozen for later analysis. BAL cell pellets were resuspended in PBS for 
total and differential cell counts. Total BAL leukocyte counts were determined for 
each mouse via light microscopy using trypan blue exclusion. BAL cells were 
centrifuged onto slides using a Cytospin centrifuge (Thermo scientifics). 
10
Differential cell counts were determined by Diff-Quick® staining reagent (Merck, 
Germany) of air-dried and fixed cytospin slides.
4. Measurement of released cytokines
The concentrations of interleukin (IL) - 4, 5 and 13 in BAL fluid were measured 
by ELISA (R&D Systems, Minneapolis, MN) as manufacturer’s instructions. 
Briefly, ELISA plates were coated with purified anti-cytokine antibodies and 
blocked with 1% BSA-PBS for 1h. Samples and dilution standards were loaded and 
incubated for 2 hr at room temperature. The bounded cytokine was detected with 
anti-mouse-cytokine antibodies for 2 hr, followed by streptavidin-HRP for 20 min. 
The plates were developed by addition of the substrate a tetramethylbenzidine 
(TMB) (KPL, Gaithersburg, MD) and stopped with 2N Sulfuric acid. Plates were 
read at 450nm.
11
5. Measurement of total IgE and OVA-specific IgE
Blood was collected by cardiac puncture. Serum total IgE level was measured 
using mouse IgE ELISA assay kit (BD bioscience, San Diego, CA) according to the 
manufacturer’s instructions. Microplates were coated with anti–IgE antibody in 
coating buffer. Serum samples and diluted standards were added and incubated for 
2 hr at room temperature. After washing, detection antibody and SAv-HRP regent 
were applied on to plate for 2 hr at room temperature. The reaction was developed 
with a TMB (KPL) and stopped with 2N Sulfuric acid. Plates were read at 450nm.
6. Lung fixation and histology
Lung sections were stained with hematoxyline and eosin (H&E). Birefly, left lung 
was fixed with 10% buffered formalin, embedded in paraffin and cut into 5-μm 
sections for H&E staining to assess airway inflammation respectively. 
Microphotographs were taken by Nikon microscope (Elipes 90i) with camera. 
12
7. Airway Hyperresponsiveness
Airway hyperresponsiveness (AHR) to methacholine (Mch; Sigma-Aldrich) was 
measured by animal ventilator (Flexivent; SCIREQ, Montreal, QC, Canada). 
Anaesthetized and tracheotomized mice were challenged with aerosolized saline or 
Mch in increasing concentrations (3.125 - 50 mg/ml). Lung resistance (Rn) was 
calculated from measures of pressure and flow and expressed as cm/H20/ml/s.
8. Preparation of Leukocyte 
Spleen, lymph nodes (LN), thymus were removed from mice, and single-cell 
suspensions were prepared. 
Lungs were minced finely. The tissues were then transferred into digestion 
solution (PBS, containing 0.75 mg/ml type I collagenase and 2 mg/ml DNase I; 
roche, Freehold, NJ) and were incubated for 1 hr at 37 °C with agitation. Digested 
tissue were transferred to and ground through a cell strainer using a syringe plunger. 
Red blood cells were lysed using ACK lysis buffer (150mM NH4Cl, 10mM KHCO3, 
13
0.1mM Na2EDTA, pH 7.2-7.4). Cells were centrifuged (5 min, 4℃, 300g) and the 
cell pellets were washed with RPMI-1640-10% FBS medium and counted.
The spleens (SPL) and mediastinal lymph nodes (mLN) were transferred into cell 
strainers; the cells were passed through the strainer using plungers, then the cells 
were washed and resuspended in fresh medium. The red blood cells were lysed 
using ACK lysis buffer for 5 min. The cells were washed again and the cell 
numbers were determined as above.
9. Isolation of CD4+ T cell 
A. Isolation of CD3+ T cells using AutoMACS
The single cells were washed and then resuspended in MACS buffer (PBS, pH=7.2, 
5 % BSA, 2 mM EDTA) per 107 total cells, then CD3ε-specific antibody (Miltenyi 
Biotec, Auburn, CA) per were added to the suspension, which was then mixed and 
incubated for 15 min at 4°C. The cells were then washed with 1 ml of MACS buffer 
and centrifuged at 300 x g for 10 min and the cells resuspended in MACS buffer, 
14
and then anti- microbeads (Miltenyi Biotec) were added to the suspension for 10 
min at 4°C. The cells were then washed with MACS buffer and centrifuged and the 
cells resuspended in 500 μl of MACS buffer. The cell suspension was applied onto 
the AutoMACS (Miltenyi Biotec). The marker negative- and positive- cells were 
collected. 
B. Isolation of CD4+CD25+ and CD4+CD25- T cells using FACS Aria II
To sort CD4+CD25+ T cells, CD3+cells were resuspened in FACS buffer and 
stained with anti-CD25-APC (eBioscience), anti-CD4-FITC (eBioscience), then 
incubated for 30 min at 4 ℃. After washing cells with FACS buffer (5% FBS in 
PBS) and sorted on a BD Biosciences FACSAria II (BD Biosciences, San Jose, CA). 
10. Flow cytometry 
Single-cell suspensions (1 X 106 to 2 X 106 cells) were resuspended in 100 μl of 
FACS buffer (0.5% FBS in PBS) and blocked with anti-CD16/32 (San Diego, CA, 
15
BioLegend, USA) and simultaneously stained with optimal concentrations of mAbs
specific for CD4 (clone RM4.5), CD8 (clone 53-6.7), CD25 (clone PC61.5), CD44 
(clone IM7), CD62L (clone MEL-14), and CD103 (clone M290). All mAbs were 
obtained from eBioscience (San Diego, CA, USA). Cells were stained for 30 min at 
4˚C, washed twice with cold staining buffer (PBS, 2% FCS, and 0.02% sodium 
azide). Samples were run on a FACS LSRII flow cytometer (BD Biosciences), and 
data were analyzed using FlowJo software (Tree Star, Ashland, OR).
For intracellular staining, cells were washed twice with PBS and centrifuged to 
remove the supernatant, then treated with RPMI-1640 medium containing 10% FBS 
and 50 ng/mL PMA (Sigma-Aldrich) and 500 ng/ mL ionomycin (Sigma-Aldrich), 
and incubated in a 5% CO2 incubator at 37°C for 4 hr. Incubated cells were then 
collected, centrifuged and incubated in the dark at 4℃ for 30 min with anti-mouse 
surface antibodies. 1 ml of freshly prepared Foxp3 Staining Kit (eBioscience) was 
added to each sample, pulse vortexed, and incubated at 4℃ for 1 hr in the dark. 
Cells were washed twice with 2 ml of permeabilization buffer. Foxp3 (clone FJK-
16
16s) and GATA3 (clone L50-823) were added in 100 μl of permeabilization buffer, 
incubated at 4℃ for 45 min in the dark, and then washed twice with 2 ml of 
permeabilization buffer. Samples were run on a FACS LSRII flow cytometer (BD 
Biosciences), and data were analyzed using FlowJo software (Tree Star, Ashland, 
OR).
11. In vitro Induction of Foxp3+ Treg
Splenic CD4+CD25-CD62LhiCD44low T cells were cultured at density of 2X105
cell/well in flat bottom 96-well plates precoated with anti-CD3 (2 μl/ml). Cells were 
cultured for 72 hr with rIL-2 (100 U/ml) in the presence or absence of different 
concentrations of recombinant human TGF-β1 (R &D systems; 1–10 ng/ml). Foxp3 
expression was assessed by flow cytometry and real-time PCR. 
For Treg suppression assay, OTII or Chit1-/- OTII Tresps (5X104/well) were 
cocultured separately with OTII or Chit1-/- OTII Tregs at different ratios, as 
17
indicated, along with mitomycon C (20 μg/ml)-treated APCs (5X104/well) plus 
anti-CD3 (2 μg/ml) or 10 μg/ml OVA for 72 hr. Plates were pulsed with CCK-8, 
and cell proliferation in triplicates was measured at 405 nm using ELISA reader.
12. T cell proliferation
CD4+CD25+ and CD4+CD25- T cells were labeled with CFSE (2 μM; Invitrogen) 
for 20 min at 37°C, washed, and then cultured for 72 hr in the presence of 2 μ g 
anti-CD28, 4 μg anti-CD3 antibody and recombinant IL-2 (10 U/ml; R&D systems). 
After 5 days, cells were fixed, permeabilized and stained with anti-mouse Foxp3 
antibody (eBioscience) and anti-mouse CD4 antibody (eBioscience). T cell 
proliferation was determined using the CCK-8 (Roche, Heidelberg, Germany).
13. Real-time RT-PCR
Total RNA was prepared with TRIzol reagent (Invitrogen). First strand cDNA was 
synthesized using superscript with random hexamer primers (Invitrogen). Real-time 
18
PCR was performed with a Exicycler 96 (Bioneer, Korea), and message levels were 
quantified using the AccuPower® GreenStar qPCR Master Mix (Bioneer), 
according to the manufacturer’s instructions. Amplification was conducted for 45 
cycles. The recovered PCR product and amplicon were checked by agarose gel 
electrophoresis for a single band of the expected size. The relative expression of 
Foxp3 was determined by normalizing expression of each target to GAPDH. 
14. Cell culture
Splenic CD4+CD25- T cells sorted by flow cytometry were used at a density of 
1X106 cell/ml in flate bottom 96-well plates precoated with anti-CD3 (2 μg/ml). 
Cells were cultured for 72 hr with IL-2 (100U/ml) in the presence or absence of 
different concentrations of recombinant human TGF-β1 and/or mouse chitotriosiase 
(R&D systems). Foxp3 expression was assessed by flow cytometry and real-time 
PCR. 
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15. Subject
A total of 80 children were enrolled in this study. The children were divided into 
2 groups, atopic asthma and controls. Asthma was defined as bronchial 
hyperresponsiveness (BHR) in the methacholine challenge (PC20 ≤16 mg/ml) or at 
least 12% reversibility of forced expiratory volume in 1 s (FEV1) after inhalation of 
β2 agonist accompanied by any typical asthma symptoms. Among the 40 asthma 
patients, 17 were mild persistent asthma and 23 were moderate-to-severe persistent 
asthma 18. Children treated with systemic corticosteroids due to asthma exacerbation 
in the preceding month were excluded from the study. The control group visited the 
hospital for general health workup or vaccination. And they had no history of 
chronic diseases, recurrent wheezing, or respiratory infection for at least 4 weeks 
prior to the evaluation. Total serum immunoglobulin E (IgE) levels, peripheral 
blood eosinophil count, and eosinophil cationic protein (ECP) levels were 
determined at the initiation of the evaluations. A specific IgE test was performed 
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with 6 allergens common in Korea: Dermatophagoides pteronyssinus, 
Dermatophagoides farina, egg whites, cow milk, German cockroach, and Alternaria 
alternata. Atopy was defined as more than 0.7 KUa/L specific IgE to more than one 
allergen, or 150 IU/ml total IgE. Atopy was defined as more than one positive skin 
test result of 12 common aeroallergens, including 2 types of dust mites, cat and dog 
epithelium, as well as mold and pollen allergens. This study was approved by the 
Institutional Review Board of Severance Hospital (Seoul, Korea) (4-2004-0036).
16. Statistical analyses 
Data are expressed as mean±SD. significant differences between two groups were 
estimated using unpaired Stud ent’s t-test. Statistical significant was set at p≤0.05.
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III. RESULTS
1. Chit1 regulates OVA-induced airway inflammation and airway 
hyperresponsiveness
To determine the contribution of the Chit1 in Th2 inflammation in asthma, we 
compared the expression of Chit1 in lungs from control mice and that had been 
sensitized and challenged with the chitin-free antigen OVA. These studies 
demonstrated that the levels of Chit1 mRNA and protein were significantly 
increased after OVA sensitization and challenge (Fig. 1A and B).
In immunohistochemistry, Chit1 expressed localized predominantly within airway 
epithelial cells and alveolar macrophages (Fig. 1C).  Thus, Chit1 is prominently 
induced during the course of chitin-free antigen-induced Th2 inflammation. 
To begin to assess the mechanisms that underlie the Th2 response in Chit null 
mutant (Chit1 -/-) mice, studies were undertaken to determine if Chit1 played a role 
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in OVA-induced allergen sensitization. In these experiments, WT and Chit1 -/- mice 
received i.p. OVA plus alum. They were then boosted with antigen and antigen-
induced inflammatory cell proliferation, the levels of total and antigen-specific IgE 
and AHR were assessed. 
In WT mice, OVA-plus-alum sensitization and challenge caused a significant 
increase in tissue inflammation and BAL total cell, eosinophil, and lymphocyte 
recovery, increases in the levels of total and OVA-specific IgE and AHR (Fig. 1D-F) 
and exhibited increased histological changes, as demonstrated by perivascular and 
peribronchiolar inflammatory cell infiltration (Fig. 1G) In these experiment systems, 
null mutations of Chit1 showed a significant increase in each of these parameters
compare to WT (Fig. 1D-G).
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Figure 1. Chit1 regulates OVA-induced airway inflammation and airway 
hperresponsiveness. WT and Chit1-/- mice were sensitized OVA/Alum and 
challenged with OVA. The level of Chit1 was assessed via western blot (A), ELISA
and real-time PCR (B). Immunohistochemistry was used to localize the Chit1 (C). 
Total cells and inflammatory cell were enumerated in BAL fluid (D). Total and 
OVA-specific IgE (E) and airway hyperreponsiveness were measured (F), and H&E 
stain of lung sections (G). Mean data was estimated from triplicated experiments. 
* p<0.05 (control vs. OVA), # p<0.05 (WT/OVA vs. Chit1-/-/OVA).
26
2. Chit1 regulates the expression of Th2 cytokines, TGF-β and IL-10 in 
asthma mouse model
In Chit1-/- mice, OVA-plus-alum sensitization and challenge caused significant
increases in inflammatory parameters compare to WT mice. Next, we identified 
inflammation related cytokines. Higher Th2 cytokine induction was noted in mice 
with null mutations of Chit1, with lung IL-13 and IL-5 being increased by 1.5~ 1.9 
fold (Fig. 2A and B). Importantly, Treg related cytokine TGF-β1 and IL-10 were 
decreased (Fig. 2C) compare to WT/OVA. When viewed in combination, these 
studies demonstrate that Chit1 plays a critical role in Th2 inflammation, 
physiological dysregulation, and Treg related cytokine production. 
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Figure 2. Chit1 regulates the expression of Th2 cytokines, TGF-β and IL-10 in 
asthma mouse model. WT and Chit1-/- mice were sensitized OVA/Alum and 
challenged with OVA. The level of Chit1 in BAL fluid from PBS- or OVA-
challenged mice, were measured by ELISA (A and C). RNA levels of cytokines in 
the lung quantified by real-time RT-PCR (B and D). Mean data and fold increases 
were estimated from triplicated experiments. * p<0.05, **p<0.01, ***p<0.005.
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3. The absence of Chit1 increased the number of GATA3+Foxp3- T cells in 
asthma mouse model
To identify whether the exaggerated Th2 response after OVA exposure in Chit1-/-
mice was driven an augmented Th2 response by depressed regulatory T (Treg) cell
related cytokines that we noted. Th2 differentiation was measured by the induction 
of GATA3, one of the main transcription factors, which potentiates Th2 responses, 
whereas Treg differentiation was measured by the induction of FOXP36,19. We next 
compared the GATA3+ effector T cell (Teff) and Foxp3+ Treg in madiastinal lymph 
nodes, spleens and lungs from WT and Chit1-/- mice. In these experiments, the 
numbers of Teff (CD3+CD4+GATA3+) and Treg (CD3+CD4+Foxp3+) were 
increased from WT and Chit1-/- mice that had been sensitized and challenged with 
OVA (Fig. 3A and B). Importantly, the dominant expression of GATA3+ occurred in 
the lung of OVA challenged mice from both WT and Chit1-/-. However, in WT mice, 
the ration of GATA3/Foxp3 was significantly lower than Chit1-/- mice, and that the 
GATA3+Foxp3- T cell was predominantly expressed in lungs of Chit1-/- OVA 
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challenged mice. These results indicate that Chit1 is one of the pathways for OVA 
induced airway inflammation and is closely related to development, expansion and 
occurrence of GATA3+ T cell and Th2 type inflammation. 
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Figure 3. The absence of Chit1 increased the number of GATA3+/Foxp3- T cells 
in asthma mouse model.  (A) After 24 hr of last OVA challenge, cells were 
isolated from mLN, spleen and lung from WT and Chit1-/- mice, stained with anti-
CD4, Foxp3 and GATA3 and analyzed by flow cytometry. (B)  Graphs are 
representing absolute numbers of CD4+GATA3+, CD4+Foxp3+ and 
CD4+GATA3+Foxp3+ cells in two groups. Mean frequency was estimated from 
triplicated experiments. * p<0.05.
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4. The absence of Chit1 does not affect the cell numbers, Foxp3 expression 
and proliferation without allergen challenge
Chit1-/- mice with OVA challenged present with lower CD4+GATA-Foxp3+ and 
CD4+GATA+Foxp3+ expression. We therefore investigated whether Chit1 
deficiency would affect Foxp+ Treg development in vivo. However, following 
examination of the thymus, spleen, mLN and other pheripheral LN (axillary and 
brachial), similar frequencies (Fig. 4A) and absolute numbers (Fig. 4B) of 
CD4+Foxp3+ T cells showed in WT and Chit1-/- mice. This result suggests that Chit1 
does not regulate Foxp3+ Treg development under steady-state conditions.
Next, we examined whether Chit1 deficiency would affect Treg cell proliferation. 
Peripheral Tregs were purified by magnetic selection and FACS from WT and 
Chit1-/- mice, and their ability to proliferate following in vitro TCR stimulation in 
the presence of exogenous IL-2 was evaluated by CFSE dilution and CCK-8 
detection. Both WT and Chit1-/- CD4+CD25+ T cells were strongly proliferated (Fig 
4C). We then tested the functionality of Chit1-/- Tregs in vitro                                                                                                                     
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suppression of T cell proliferation. Using highly purified CD4+CD25+ T cells, we 
found that Chit1-/- Tregs were also effective at suppressing the increased 
proliferation of WT CD4+CD25- (Tresps) as WT Tregs (Fig. 4D). Therefore, Chit1-
deficient Foxp3+ Tregs are presented with normal proliferation and suppression 
ability.
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Figure 4. The absence of Chit1 does not affect the cell numbers, Foxp3 
expression and proliferation without allergen challenge. (A) Cells were isolated 
from thymus, spleen and LN from WT and Chit1-/- mice, stained with CD4 and 
Foxp3 and analyzed. (B) Graphs representing absolute numbers of total cells in age-
and sex- matched mice WT and Chit1-/- mice. (C) Purified CD4+ CD25+ cells were 
labeled with CFSE and stimulated with plate bounded anti-CD3/CD28 in the 
presence of IL-2. After 72 hr, Treg proliferation was evaluated by CFSE dilution. (D) 
Suppression of T cell-proliferative response by CD4+CD25+ T cells sorted from WT 
and Chit1-/- mice following co-culture with WT CD4+CD25- (Tresps) cells. 
Proliferation was assessed as CCK-8 incorporation. Proliferations are representative 
of at least three independent experiments. * p<0.05.
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5. TGF-β or Chit1 stimulation enhance the differentiation of Foxp3+ iTreg 
cells in a dose dependent way.
Because OVA-challenged Chit1deficiency mice impaired in Foxp3 induction, we 
hypothesized that Chit1 might be important for Treg induction, and we therefore 
examined whether Chit1 deficiency would affect Foxp3 induction in CD4+T cells. 
Purified naïve reponse (CD4+CD25-CD62LhiCD44low) T cells were stimulated with 
TGF-β1 and Foxp3 expression levels examined after 4 day in culture. It was interest 
to investigate whether Chit1 regulated the development and/or Foxp3+ T cells. 
Following 3 day of culture with TGF-β1 only, the frequency of CD4+Foxp3+ Treg
cells were significantly lower in the absence of Chit1 when compared with WT (Fig. 
5). We consequently examined the Chit1 effect on Foxp3+ Treg of WT and Chit1-/-
CD4+CD25-T cells stimulated with TGF-β1 and/or Chit1 following 4 day of culture. 
Stimulation of CD4+CD25-T with Chit1 led to Foxp3+ Treg cells. However, 
significantly higher frequency of Foxp3+ Treg cell was detected in the presence of 
both TGF-β1 and Chit1, as compared with TGF-β1 stimulation only. Otherwise 
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stimulation of Chit1 only did not induced Foxp3+ Treg and did not showed 
synergistic effect on iTreg induction in WT (Fig. 5A and B). TGF-β1 or Chit1 
treatment induced TGF-β II receptor expression but both TGF-β1 and Chit1
treatment were showed highest mRNA expression (Fig. 5D).  These data suggested 
that Chit1 deficiency impaired that development of CD4+Foxp3+ Treg cells in the 
periphery. 
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Figure 5. TGF-β1 or Chit1 stimulation enhance the differentiation of Foxp3+
iTreg cells in a dose dependent way. CD4+CD25- cells were isolated from spleen 
from WT and Chit1-/- mice. The cells were then stimulated with plate bound-anti 
CD3 and anti-CD28 in the presence of IL-2 and different concentrations of TGF-β1
or Chit1. After 72 hr, cells were harvested and stained with anti-CD4/Foxp3 and 
were subjected to FACS (A and B) and TGF- β receptor II mRNA expression were 
real-time PCR (C) evaluation. * p<0.05.
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6. Chit1 regulates House dust mite-induced airway inflammation and airway 
hperresponsiveness
Hallmark indicators of allergic asthma include airway eosinophilia and the 
production of mucin, Th2-patterned cytokines, and IgE Abs. We also tested the role 
of Chit1 in the chitin-containing antigen-driven systems. To assess the influence of 
Chit1 on these parameters, Chit1-/- and WT mice were sensitized and challenged 
with house dust mice (HDM), and the lungs were lavaged, excised, and prepared 
for analysis. As expected, HDM-treated mice was increased the level of Chit in 
BAL fluid (Fig. 6A). The Chit1-/- HDM mice exhibited increased total cell and 
eosinophil counts (Fig. 6B) in the BAL fluid compared with their WT counterparts. 
Chit1-/-/OVA mice had greater BAL fluid IL-4, IL-5 and IL-13 protein levels but not 
TGF-β1 and IL-10 (Fig. 6C) and serum IgE levels (Fig. 6D) compared with WT 
HDM mice. WT and Chit1-/- HDM mice exhibited the expected HDM mediated 
histological changes, as demonstrated by perivascular and peribronchiolar 
inflammatory cell infiltration (Fig. 6E), suggesting that Chit1 modulates the extent 
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of the Th2 response and subsequent humoral response in allergen mediated lung 
inflammation.
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Figure 6. Chit1 regulates House dust mite-induced airway inflammation and 
airway hperresponsiveness. WT and Chit1-/- mice were sensitized house dust mite 
(HDM)/Alum and challenged with HDM. The level of Chit1 was assessed via 
ELISA (A) using BAL fluid. BAL total and inflammatory cell recovery were 
quantitated (B), cytokine (C), total IgE (D) and airway hyperreponsiveness were 
measured (F), and  H&E stain of lung sections (E) Mean frequency and fold 
increases were estimated from triplicated experiments. * p<0.05, **p<0.01, 
***p<0.005 (control vs. OVA ), # p<0.05 (WT/OVA vs. Chit1-/-/OVA).
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7. Chit1 expression is increased in pediatric asthma patients
To determine whether Chit1 expression is increase in the circulation and 
sputum of patients with asthma we applied ELISA approaches to the serum and 
sputum samples. The clinical characteristics of the study subjects are summarized 
in Table 1. There were no significant differences in age and gender between the 
groups. The percentage of children with atopy was significantly higher in asthma 
group than those in control group (p < 0.001). Pulmonary function parameters, 
including FEV1 (p < 0.001), percentage change in FEV1 after BD therapy (p < 
0.001), FEV1/FVC (p < 0.001), and forced expiratory flow midexpiratory phase 
(FEF25–75) [p < 0.001], showed significantly lower levels in children with asthma 
than in control subjects. Asthma subjects showed lower levels in FVC, but there 
was no statistical difference (p=0.054). The percentage of eosinophils in induced 
sputum was significantly higher in children with asthma than in control subjects (p
< 0.001). The blood eosinophil count, serum ECP, and serum total IgE levels were 
increased in children with asthma compared with those in control subjects (P < 
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0.001).
Compared with control samples, which showed only modest levels of chit1, the 
levels of sputum and serum Chit1 were higher in patients with asthma 
(41.1±23.288 versus 53.65±4.6, 48.43±1.712 versus 53.58±1.945; Fig. 7A and B). 
This suggests that Chit1 may be a useful biomarker of disease in this patient 
population. 
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(A)                                 (B)
Figure 7. Chit1 expression is increase from pediatric patients with asthma. 
Comparison of normal controls (left, n=40) versus asthma subjects (right, n=40) 
reveals significantly increased Chit1 concentration in (A) sputum and (B) serum in 
asthma. (A) The level of Chit1 is enhanced in patients with asthma (right, n=40) 
compare to normal control (left, n=40) in suptum. 
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Table 1. Subject characteristics
Characteristics Asthma (n=40) Control (n=40)
Age, yr 9.2 ± 2.1  9.1 ± 2.6
Sex, M (%) 26 (65) 18 (45)
Atopy, with (%) 40 (100)* 0 (0)
FVC, % pred 88.9 (76.1-95.8) 90.1 (83.9-104.3)
FEV1, % pred 94.5 (85.0-103.1)* 98.5 (92.5-106.8)
Change in FEV1, % 5.8 (3.3-14.3)* 4.25 (3.3 -6.0)
FEV1/FVC, % 94.3 (86.1-98.7)* 97.3 (91.5-99.0)
FEF25-75, % pred 91 (76.4-108.9)* 101.1 (89.3-118.0)
Total IgE, IU/mL 79.8 (10.3-708) 10.4 (4.8-21.0)
Blood eosinophil, uL 230 (120-560)* 120 (70-180)
Serum ECP, ug/L 14.4 (6.8-28.1)* 7.5 (4.9-17.3)
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Values are expressed as number (percentage), mean ± SD, or median (Interquatile 
range) *p < 0.001 compared to control subjects. FVC, forced expiratory vital 
capacity; FEV1, forced expiratory volume in 1 sec; FEF25-75, forced expiratory 
flow between 25% and 75%; IgE, immunoglobulin E; ECP, eosinophil cationic 
protein. 
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IV. DISCUSSION
The present studies demonstrate that the regulation of Chit1 in a murine model of 
allergen allergic airway disease amplifies the inflammatory response and leads to a 
higher percentage of CD4+GATA3+ T cells within the lungs of Chit1-/- mice.
Moreover, allergen-challenged Chit1-/- lung produced increased IL-4, 5 and 13
cytokine levels upon Th2 polarization compared to wild type mice. Whereas lower
level of TGF-β1 and IL-10 were exhibited in BAL and lung from Chit1-/- mice.
Adding exogenous recombinant TGF-β1 and Chit1 in vitro to replicate its function
correspondingly increase the proportion of Foxp3+ T cells. These studies 
demonstrate that Chit1 mediates these effects, at least in part, by synergizing with 
TGF-β1. Lastly, we compared the level of Chit1 in sputum and serum was increased 
in asthma patients compare to healthy control.
The present studies have revealed a regulatory profile with Chit1 contributing to 
the pathogenesis of adaptive Th2 inflammation in chitin-free experimental systems. 
However, our data also demonstrates that deficiency of Chit1 has similar effects in 
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chitin-free and chitin-containing antigen-driven systems. This finding suggests that 
the contributions of Chit1 in this setting may also be independent of its chitinase 
enzyme activity. 
Our data showed that Chit1 is required for TGF-β1 mediated Foxp3 induction in 
allergen stimulated T cell development. The fate of CD4+T cells is governed by the 
cytokines they encounter, leading to the increase expression of master regulators, 
determining in particular their cytokine secretion profile. As reported by many 
studied, CD4+ lineages have some degree of plasticity, allowing coexpression of 
master transcriptional regulators and cytokines specific for other lineages. Indeed, 
Chit1 involve in TGF- β1- induced receptor expression and signaling by activation 
of TGF-β receptor (TGFβR) at that expense of Treg induction. These observations 
are well supported by several recent studies showing that in the presence of both 
TGF- β1 and Chit1, enhance to induce TGFβR expression and TGF- β1 signaling 
compare to TGF- β1 alone.16,20
Chit1 bioactivity and protein levels were significantly increased in the circulation 
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and lung of patients compared to controlls.21 Using animal models, they further 
demonstrated that Chit1 enhances TGFβR expression and its signaling in fibroblasts. 
And Chit1 augmented TGF- β1–induced Smad2 phosphorylation, Smad2 reporter 
activation and MAPK ERK1/2 phosphorylation. Thus they identified that Chit1 
interacts with TGF- β1 to augment TGF- β1 receptor expression and TGF- β1
signaling.16,22,23 In this regard, our results show that in the absence of Chit1, failure 
to induction Foxp3+ Tregs is associated with the loss of activation of TGFβR
expression and TGF- β1 signaling and consequently acquisition of Th2 phenotype, 
likely due to increased GATA3 expression levels. Therefore, TGFβR and TGF- β1
signaling activation levels seems to be required for an acquisition of Foxp3+ 
phenotype, and Chit1 may play a synergetic role in this process.
Previous study demonstrated that Foxp3 induction is inhibited by GATA3, which 
is the key regulator for polarization toward Th2 cells. After differentiation, the 
effector Th2 cells become refractory to conversion into a Foxp3+ phenotype.24
GATA3 repressed Foxp3 expression directly by binding to the Foxp3 promoter 
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region. Naïve T cells could efficiently up-regulate Foxp3 when treated with TGF-β
to iTreg cells, but already-committed cells such as memory T cells and Th1 cells 
showed not sufficient to change the phenotype toward a regulatory T cell profile. 
And the Th2 cytokine IL-4 but not IL-13 were able to inhibit TGF- β -mediated 
Foxp3 induction and therefore prevented conversion into the regulatory 
phenotype.25 Similar effects have been recently described for IL-6, which combined 
with TGF- β, inhibits the generation of iTreg cells and induces differentiation into 
the Th17 cells by an unknown mechanism.26 In this sense, GATA3 restrains the 
development of Treg subsets of the inducible and peripheral population. We have 
shown that the level of TGF- β was significantly low in allergen-induced Chit1-/-
mice. In addition to, the deficiency of Chit1 leads to the enhanced frequency of 
GATA3+ T cells and level of IL-4 in allergen challenged mice, which may be 
responsible for the decreased Foxp3+ T cell differentiation in Chit1-/-. Thus Chit1 
could function to promote TGF- β -mediated Treg pathways and dampen T cell 
activation in the site of inflammation. 
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V. CONCLUSION
Based on our findings, the presence of adequate amounts of Chit1 in the lung 
milieu positively regulates the prevalence of Foxp3+ Treg cells in the lung tissue 
during allergen-induced inflammation. Because of a deficiency of Chit1, there is a 
concomitant decrease in the production of Treg-associated cytokines, which, in turn, 
affects the induction of Tregs and increased the Th2-associated inflammation 
response. Thus, Chit1 regulate Treg induction synergically from acquiring Th2 
effector characteristics by cooperating with TGF-β1-induced Treg induction. 
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ABSTRACT (IN KOREAN)
알러젠으로 유도된 천식 마우스에서 Chitotriosidase의 알레르기
면역 반응 조절 연구
<지도교수 손 명 현>
연세대학교 대학원 의과학과
홍 정 연
인간에 존재하는 true chitinase 중 Acidic mammalian chitinase 
(AMCase) 와 Chitotriosidase  (Chitinase 1, chit1)는 기관지 염증 또
는 변형에 중요한 조절자로 알려져 있다. 알러지성 천식은 Th2 세포들이
생성하는 사이토카인, 호산구, 기도 과민성의 증가를 특징으로 한다. 그
러나 이러한 Th2 반응에서의 Chit1의 역할과 메커니즘에 대한 연구는 밝
혀진 것이 없다.
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6주령 된 C57BL/6 를 background로 갖는 wild type (WT)과 Chit1 
Knock out (Chit1-/-) 마우스에 ovalbumin (OVA)과 house dust mite (HDM)
을 복강을 통해 감작시키고 기도에 처리하여 알러지성 기도 염증을 유도
하였다. 기관지 폐포 세척액 (Bronchoalveolar lavage fluid; BALF) 에
서 총 세포와 염증 세포수를 측정하고 사이토카인과 IgE 농도는 ELSIA로
측정하였다. 메타콜린 흡입에 따른 기도과민성 (airway 
hyperresponsiveness; AHR) 은 Flexivent apparatus를 이용하여 측정한
다. 마우스의 비장, 림프절, 폐에서 분리한 세포는 OVA로 재감작을 하거
나 분리한 CD4+CD25- T 세포에 TGF-β 와 Chit1를 처리하여 Treg을 유도
한 뒤 유세포 분석기를 이용해 세포를 분석한다.
OVA에 의해 유도된 Chit1-/- 군은 WT군에 비해 저항값, 기관지폐포세척
액 내의 염증세포 수, IL-5 및 IL-13 농도, 혈청 내의 총 또는 OVA 특이
IgE 농도, 폐조직 내 염증세포의 과다형성 정도가 유의하게 높게 측정되
었으나 TGF-β1 과 IL-10 의 농도는 유의하게 낮게 측정되었다. 특히 천
식 마우스군 폐에서 측정한 CD4+Foxp3+/CD4+GATA3+ 비율과 절대 세포수도
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Chit1-/- 군에서 유의하게 낮은 수치를 나타냈다. 또한 분리한 CD4+CD25- T 
세포에 TGF-β 와 Chit1을 처리하여 Treg 세포 분화 유도시 TGF-β1 과
Chit1를 함께 처리해준 Chit1-/- 군에서 가장 높은 분화효과를 확인할 수
있었다.
또한 chitin이 포함된 HDM를 이용한 천식마우스 모델에서도 Chit1-/- 마
우스는 WT에 비해 염증관련 parameter들이 모두 증가되어 있었으나 TGF-
β1 과 IL-10 의 농도는 유의하게 낮게 측정되었다.
마지막으로 천식환자의 가래와 혈청에서 Chit1의 농도를 측정한 결과
정상군에 비해 유의하게 높은 Chit1 농도를 가래에서 확인 할 수 있었다.
따라서 위 결과를 통해 알러젠 유도 천식 마우스 모델에서 Chit1이 염
증 부위에 증가되고 CD4+ T 세포 분화에 관여하여 염증 부위의 T cell 
population 을 조절하여 염증반응을 감소시키는 것을 확인하였다. 
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